Novanta NOVT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Automation Enabling Technologies | $508.91M+2.5% | $500.84M+2.1% | $497.95M+2.1% | $501.34M+3.6% | $496.4M+0.9% | |
| Medical Solutions | $496.03M+8.9% | $479.76M+4.6% | $462.36M-5.0% | $455.54M+0.3% | $455.3M+8.8% | |
| Robotics And Automation | $324.16M+6.7% | $318.58M+10.5% | $314.23M+14.9% | $314.12M+20.7% | $303.68M+14.7% | |
| Segment Operating Income by Business | ||||||
| Automation Enabling Technologies | $114.19M+0.2% | $114.53M+7.6% | $116.6M+17.1% | $119.32M+27.5% | $113.96M+18.5% | |
| Medical Solutions | $53.87M-3.0% | $51.17M-11.1% | $43.61M-34.2% | $44.02M-33.1% | $55.54M-12.5% | |
| Gross Profit by Business | ||||||
| Automation Enabling Technologies | $242.87M+1.7% | $239.51M+1.9% | $240.72M+4.8% | $242.07M+6.2% | $238.86M+3.1% | |
| Medical Solutions | $205.91M+8.5% | $199.7M+5.1% | $193.14M-10.4% | $189.87M-5.2% | $189.7M+2.5% | |
| Accounts Receivable Net Current by Business | ||||||
| Automation Enabling Technologies | $296.77M— | $293.83M— | $287.97M— | —— | —— | |
| Medical Solutions | $393.81M— | $387.02M— | $359.02M— | —— | —— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | ||||||
| Automation Enabling Technologies | $114.19M+0.2% | $114.53M+7.6% | $116.6M+17.1% | $119.32M+27.5% | $113.96M+18.5% | |
| Medical Solutions | $53.87M-3.0% | $51.17M-11.1% | $43.61M-34.2% | $44.02M-33.1% | $55.54M-12.5% | |
| Inventory Net by Business | ||||||
| Automation Enabling Technologies | $421.99M— | $397.45M— | $376.26M— | —— | —— | |
| Medical Solutions | $307.48M— | $284.31M— | $261.83M— | —— | —— | |
| Selling General And Administrative Expense by Business | ||||||
| Automation Enabling Technologies | $77.04M+1.3% | $76.32M+1.2% | $76.06M+3.3% | $75.53M+2.3% | $76.09M+4.0% | |
| Medical Solutions | $61.61M+12.2% | $60.03M+11.6% | $58.14M+10.7% | $57.16M+12.0% | $54.91M+8.6% | |
| Restructuring Costs by Business | ||||||
| Automation Enabling Technologies | -$3.01M-188% | -$3.11M-197% | $2.42M-47.3% | $2.54M-53.7% | $3.41M-36.4% | |
| Medical Solutions | $7.83M+17.8% | $7.41M+9.4% | $11.94M+347% | $10.49M+456% | $6.65M+326% | |
| Cost of Goods Sold by Business | ||||||
| Automation Enabling Technologies | $260.63M+3.6% | $255.76M+2.6% | $251.5M0.0% | $253.44M+1.7% | $251.47M-0.7% | |
| Medical Solutions | $279.05M+8.6% | $269.36M+3.5% | $259.22M+4.3% | $256.32M+8.5% | $257.03M+16.8% | |
| D&A by Business | ||||||
| Automation Enabling Technologies | $21.16M-9.9% | $22.44M-6.0% | $22.89M-6.1% | $23.07M-8.0% | $23.49M-9.2% | |
| Medical Solutions | $39.86M+29.0% | $37.96M+27.3% | $34.64M+20.1% | $32.83M+31.5% | $30.9M+45.7% | |
| Goodwill Gross by Business | ||||||
| Automation Enabling Technologies | $1.79B— | $1.77B— | $1.77B— | —— | —— | |
| Medical Solutions | $1.4B+21.7% | $1.36B+21.4% | $1.31B+26.9% | $1.23B+34.0% | $1.15B+41.5% | |
| Amortization Of Intangible Assets by Business | ||||||
| Automation Enabling Technologies | $9.48M-12.3% | $9.77M-12.8% | $10.11M-13.2% | $10.37M-14.1% | $10.81M-13.5% | |
| Medical Solutions | $18.21M+23.2% | $17.71M+21.4% | $15.79M+24.2% | $15.2M+40.6% | $14.78M+72.4% | |
| Research And Development Expense by Business | ||||||
| Automation Enabling Technologies | $37.4M-2.8% | $37.8M-3.1% | $38.54M-2.7% | $37.76M-9.0% | $38.47M-9.0% | |
| Medical Solutions | $58.63M+1.4% | $58.34M+2.2% | $60.17M+11.3% | $60.07M+15.8% | $57.8M+14.8% | |
| Restructuring Charges And Acquisition Related Costs by Business | ||||||
| Automation Enabling Technologies | $4.76M+1,108% | $1.08M-62.8% | -$597K-111% | -$897K-113% | -$472K-106% | |
| Medical Solutions | $13.59M+104% | $12.45M+79.6% | $15.43M+634% | $13.43M+855% | $6.66M+381% | |
| Cost Of Goods And Services Sold Amortization by Business | ||||||
| Automation Enabling Technologies | $5.41M-10.8% | $5.57M-11.3% | $5.73M-11.6% | $5.83M-12.4% | $6.07M-11.4% | |
| Medical Solutions | $11.06M+29.1% | $10.71M+26.1% | $9.99M+30.7% | $9.34M+37.5% | $8.57M+44.0% | |
| Goodwill Impaired Accumulated Impairment Loss by Business | ||||||
| Automation Enabling Technologies | $478.03M— | $478.03M— | $478.03M— | —— | —— | |
| Medical Solutions | $126.89M0.0% | $126.89M0.0% | $126.89M0.0% | $126.89M0.0% | $126.89M0.0% | |
| Goodwill by Business | ||||||
| Automation Enabling Technologies | $1.31B— | $1.3B— | $1.29B— | —— | —— | |
| Medical Solutions | $1.28B+24.3% | $1.24B+24.1% | $1.18B+30.7% | $1.11B+39.4% | $1.03B+49.2% | |
| Revenue by Geography | ||||||
| CN | $95.32M+7.2% | $93.2M+10.2% | $91.36M+14.5% | $91.69M+29.4% | $88.93M+22.3% | |
| DE | $122.46M+3.3% | $114.65M-7.0% | $107.42M-15.2% | $113.88M-9.9% | $118.54M-6.3% | |
| Other Countries | $20.88M+18.0% | $19.31M+4.9% | $19.16M+15.3% | $18.4M+13.3% | $17.69M-9.5% | |
| Rest Of Asia Pacific | $101.04M-2.1% | $97.03M-9.4% | $99.8M-5.4% | $102.51M+0.1% | $103.18M-1.3% | |
| Rest Of Europe | $147.87M+14.0% | $137.41M+6.6% | $138.08M+3.9% | $132M-3.4% | $129.68M-6.5% | |
| US | $517.38M+4.8% | $519.01M+6.5% | $504.5M+9.4% | $498.41M+11.4% | $493.68M+14.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Novanta break its business down?
- Novanta (NOVT) reports revenue by business across 3 parts — Automation Enabling Technologies, Medical Solutions and Robotics And Automation. Each is extracted from the segment footnotes and tracked over time.
- Where does Novanta's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Novanta's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.